FdaApplication

ANDA 213206

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2023-05-26

Products (1)

ProductActive ingredientStrengthDosage form
VASOPRESSINVASOPRESSIN20UNITS/ML (20UNITS/ML)SOLUTION;INTRAVENOUS

1 product